RxSight (RXST) Receivables (2020 - 2026)
RxSight (RXST) posted Receivables of $22.4 million for Q1 2026, down 4.02% on a QoQ basis from $23.4 million in Q4 2025, and down 27.51% year-over-year from $31.0 million in Q1 2025.
RxSight (RXST) Receivables (2020 - 2026) Analysis & Trends
RxSight's Receivables history runs 7 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- Quarterly Receivables fell 27.51% year-over-year to $22.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.4 million (down 27.51% YoY) and the FY2025 annual result came in at $23.4 million, down 22.19% from the prior year.
- Receivables was $22.4 million for Q1 2026 at RxSight, down from $23.4 million in the prior quarter.
- Across five years, Receivables topped out at $31.0 million in Q1 2025 and bottomed at $5.6 million in Q1 2022.
- A 5-year average of $19.2 million and a median of $21.6 million in 2024 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables soared 125.34% — and 2026, when it retreated 27.51%.
- RxSight's Receivables stood at $11.0 million in 2022, then jumped by 85.11% to $20.3 million in 2023, then jumped by 48.17% to $30.0 million in 2024, then slipped by 22.19% to $23.4 million in 2025, then slipped by 4.02% to $22.4 million in 2026.
- Business Quant data shows RXST's Receivables at $22.4 million in Q1 2026, $23.4 million in Q4 2025, and $24.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | 22.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.44 Mn |
| Dec 31, 2025 | 23.38 Mn |
| Sep 30, 2025 | 24.15 Mn |
| Jun 30, 2025 | 28.06 Mn |
| Mar 31, 2025 | 30.96 Mn |
| Dec 31, 2024 | 30.05 Mn |
| Sep 30, 2024 | 25.37 Mn |
| Jun 30, 2024 | 25.72 Mn |
| Mar 31, 2024 | 21.55 Mn |
| Dec 31, 2023 | 20.28 Mn |
| Sep 30, 2023 | 15.24 Mn |
| Jun 30, 2023 | 13.30 Mn |
| Mar 31, 2023 | 12.67 Mn |
| Dec 31, 2022 | 10.96 Mn |
| Sep 30, 2022 | 9.02 Mn |
| Jun 30, 2022 | 6.88 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 4.86 Mn |
| Sep 30, 2021 | 4.36 Mn |
| Jun 30, 2021 | 3.94 Mn |